FIELD: pharmaceutics.
SUBSTANCE: invention relates to a novel salt - dichloroacetate {3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazole-1-yl]-1-ethylsulfonyl-azetidine-3-yl}-acetonitrile, which is Janus kinase inhibitor (JAK), wherein it exhibits selective action on JAK3. Compounds can be used for treating autoimmune disease or disorder, such as rheumatoid arthritis, psoriatic arthritis or juvenile arthritis. {3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazole-1-yl]-1-ethylsulfonyl-azetidine-3-yl}-acetonitrile dichloroacetate has formula (1):
.
Compound of formula 1 can be obtained by reaction of {3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazole-1-yl]-1-ethylsulfonyl-azetidine-3-yl}-acetonitrile with dichloroacetic acid.
EFFECT: invention also relates to pharmaceutical composition effective for treating JAK-related diseases in form of tablets, capsules or injections, placed in pharmaceutically acceptable pack, and method of treating.
9 cl, 2 tbl, 6 ex
| Title |
Year |
Author |
Number |
| 2-(3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-1-(ETHYLSULFONYL)AZETIDIN-3-YL)ACETONITRILE HEMINAPHTHYLDISULFONATE AS JANUS KINASE INHIBITOR |
2016 |
- Aleksandr Vasilevich Ivashchenko
- Ignatev Vasilij Gennadevich
- Shafeev Mikhail Ajratovich
- Repik Aleksej Evgenevich
|
RU2644155C1 |
| {3-[(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)AZOLYL]AZETIDIN-3-YL} ACETONITRILES AS JANUS KINASE INHIBITORS |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2601410C1 |
| DICHLOROACETATE OF N,N-DISUBSTITUTED N-[4-(1-METHYL-1H-INDOLE-3-YL)-PYRIMIDINE-2-YL]-5-METHOXYBENZENE-1,2,4-TRIAMINE AS EGFR MODULATOR FOR TREATING CANCER |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2603960C1 |
| 8-(1-{4-{(5-CHLORO-4-{(2-(DIMETHYLPHOSPHORYL)PHENYL)AMINO}PYRIMIDIN-2-YL)AMINO)-3-METHOXYPHENYL}PIPERIDIN-4-YL)-1-METHYL-1,8-DIAZASPIRO(4.5)DECAN-2-ONE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS AS AN ALK AND EGER MODULATOR FOR TREATMENT OF CANCER |
2017 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2654695C1 |
| SUBSTITUTED METHYL(2-{4-[3-(3-METHANESULFONYLAMINO-2-FLUORO-5-CHLORO-PHENYL)-1H-PYRAZOL-4-YL]PYRIMIDIN-2-YLAMINO}ETHYL) CARBAMATES, PROCESS FOR THEIR PREPARATION AND APPLICATION |
2016 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2615986C1 |
| SUBSTITUTED N-{3-[4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YLAMINO]-4-METHOXYPHENYL}-AMIDES AS MODULATORS OF EGFR, APPLICABLE FOR TREATING CANCER |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2606949C9 |
| DICHLOROACETATES OF SUBSTITUTED N4-[2-(DIMETHYLPHOSPHORYL)PHENYL]-N2-(2-METHOXY-4-PIPERIDIN-1-YLPHENYL)-5-CHLOROPYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, INTENDED FOR TREATING CANCER |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2606951C1 |
| DERIVATIVES OF 1-(3-AMINOPHENYL)-6,8-DIMETHYL-5-(4-IODO-2-FLUORO-PHENYLAMINO)-3-CYCLOPROPYL-1H,6H-PYRIDO[4,3-d]PYRIMIDINE-2,4,7-TRIONE AS MEK1/2 INHIBITORS |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2605400C1 |
| N-{3-[3-CYCLOPROPYL-5-(2-FLUORO-4-IODOPHENYLAMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDRO-2H-PYRIDO[4,3-D]PYRIMIDINE-1-IL]-PHENYL}-CYCLOPROPANECARBOXAMIDE DIMETHYLSULFOXIDE SOLVATE AS MEK1/2 INHIBITOR |
2016 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2627692C1 |
| TREATMENT OF HYDRADENITIS WITH JAK INHIBITORS |
2020 |
- Fensome, Andrew
- Gerstenberger, Brian Stephen
- Owen, Dafydd Rhys
|
RU2805595C1 |
